Literature DB >> 31490659

Smart Unimolecular Micelle-Based Polyprodrug with Dual-Redox Stimuli Response for Tumor Microenvironment: Enhanced in Vivo Delivery Efficiency and Tumor Penetration.

Shuang Bai1,2, Xiaoqian Ma1,2, Xiaoxiao Shi1,2, Jinjun Shao3, Tian Zhang1,2, Yajun Wang1,2, Yilong Cheng4, Peng Xue1,2, Yuejun Kang1,2, Zhigang Xu1,2.   

Abstract

Low delivery efficiency and limited tumor penetration of nanoparticle-based drug delivery systems (DDSs), the two most concerned issues in tumor therapy, have been considered as the "Achilles' heel" for tumor treatment. In this study, we have designed a highly sensitive dual-redox-responsive prodrug-based starlike polymer β-CD-b-P(CPTGSH-co-CPTROS-co-OEGMA) (CPGR) for synergistic chemotherapy. The high glutathione (GSH) concentration and high reactive oxygen species (ROS) levels are in a dynamic equilibrium in the tumor microenvironment (TME) and could trigger the disintegration of CPGR micelles, which can promote the release of anticancer drug camptothecin (CPT) completely and intelligently. In order to verify the synergistic antitumor mechanism, two corresponding single-responsive β-CD-b-P(CPTGSH-co-OEGMA) (CPG) and β-CD-b-P(CPTROS-co-OEGMA) (CPR) were altogether prepared as contrast. Both in vitro and in vivo studies confirmed the enhanced anticancer activity of CPGR micelles in comparison of single responsive micelles. This work contributes to the orchestrated design of dual-redox-responsive DDSs for synergetic antitumor chemotherapy, which provides a good approach for the development of dual-redox-responsive nanomedicine.

Entities:  

Keywords:  cancer therapy; delivery efficiency; dual-redox response; tumor microenvironment (TME); tumor penetration

Mesh:

Substances:

Year:  2019        PMID: 31490659     DOI: 10.1021/acsami.9b13214

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

Review 1.  Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation.

Authors:  K Laxmi Swetha; Kavya Sree Maravajjala; Shyh-Dar Li; Manu Smriti Singh; Aniruddha Roy
Journal:  Drug Deliv Transl Res       Date:  2022-06-13       Impact factor: 4.617

Review 2.  Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review.

Authors:  Maryam Ghanbari-Movahed; Tea Kaceli; Arijit Mondal; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Biomedicines       Date:  2021-04-27

3.  An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment.

Authors:  Bingtao Zhai; Peng Chen; Wengang Wang; Shuiping Liu; Jiao Feng; Ting Duan; Yu Xiang; Ruonan Zhang; Mingming Zhang; Xuemeng Han; Xiaying Chen; Qiujie Li; Guohua Li; Ying Liu; Xingxing Huang; Wenzheng Zhang; Ting Pan; Lili Yan; Ting Jin; Tian Xie; Xinbing Sui
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 4.  Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.

Authors:  Gengqi Liu; Jonathan F Lovell; Lei Zhang; Yumiao Zhang
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

5.  Cylindrical polymer brushes-anisotropic unimolecular micelle drug delivery system for enhancing the effectiveness of chemotherapy.

Authors:  Shuang Bai; Die Jia; Xianbin Ma; Mengyun Liang; Peng Xue; Yuejun Kang; Zhigang Xu
Journal:  Bioact Mater       Date:  2021-02-23

6.  Acidic microenvironment responsive polymeric MOF-based nanoparticles induce immunogenic cell death for combined cancer therapy.

Authors:  Xiaoli Zhang; Yi Lu; Die Jia; Wei Qiu; Xianbin Ma; Xingliang Zhang; Zhigang Xu; Feiqiu Wen
Journal:  J Nanobiotechnology       Date:  2021-12-28       Impact factor: 10.435

7.  NIR triggered PLGA coated Au-TiO2 core loaded CPT-11 nanoparticles for human papillary thyroid carcinoma therapy.

Authors:  Tianyu Yu; Lingling Tong; Yu Ao; Genmao Zhang; Yunpeng Liu; Hejia Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.